[Integrin α3β1 signaling in regulation of the SK-Mel-147 melanoma cell senescence]

Area of Science:

• Cell Biology
• Oncology
• Molecular Biology

Background:

• Integrin α3β1 is a laminin-specific receptor involved in cell adhesion and signaling.
• Cellular senescence is a state of irreversible growth arrest that can act as a tumor suppressor mechanism.
• Previous studies suggested a role for Akt signaling in regulating senescence.

Purpose of the Study:

• To investigate the role of integrin α3β1 in melanoma cell senescence.
• To elucidate the signaling pathways, particularly Akt isomers, involved in integrin α3β1-mediated senescence.
• To compare the senescence-inducing effects of α3β1 deficiency with α2β1 deficiency.

Main Methods:

• Utilized SK-Mel-147 melanoma cell line.
• Employed short hairpin RNA (shRNA) to knockdown integrin α3β1 expression.
• Assessed senescence using SA-β-Gal staining.
• Measured protein kinase activity (Akt, mTOR) and oncosuppressor expression (p53, p21).
• Used pharmacological inhibitors for mTORC1 and Akt isomers (Akt1, Akt2).

Main Results:

• Knockdown of integrin α3β1 increased SA-β-Gal-positive cells, indicating senescence, without affecting proliferation.
• Integrin α3β1 depletion led to increased Akt and mTOR kinase activity and elevated p53 and p21 levels.
• Inhibition of mTORC1 reduced senescence in α3β1-depleted cells.
• Inhibition of Akt1, but not Akt2, decreased the number of senescent cells in the α3β1 knockdown model.
• These findings suggest a signaling pathway involving Akt1 in α3β1-deficiency-induced senescence.

Conclusions:

• Integrin α3β1 plays a crucial role in protecting tumor cells from senescence, similar to integrin α2β1.
• Senescence induced by integrin α3β1 depletion relies on a signaling mechanism involving the non-canonical function of Akt1.
• Targeting integrin α3β1 or the Akt1 pathway may represent a novel therapeutic strategy for melanoma.